GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Haleon plc
Haleon, a spinoff from GSK, owns a portfolio of well-known over-the-counter brands such as Advil and Sensodyne. Its shares are a classic defensive asset. The chart shows stability based on everyday demand for health products.
Share prices of companies in the market segment - Pharma other
Haleon, spun off from GSK, is one of the world's largest companies producing over-the-counter consumer healthcare products (Advil, Sensodyne). We classify it as part of the Pharmaceutical Other sector, and the chart below reflects the overall performance of this segment.
Broad Market Index - GURU.Markets
Haleon is one of the world's largest consumer health companies, owning brands such as Sensodyne and Advil. Its scale makes it a component of the GURU.Markets index. The chart below represents the market. See how Haleon shares compare to the consumer sector.
Change in the price of a company, segment, and market as a whole per day
HLN - Daily change in the company's share price Haleon plc
Haleon, spun off from GSK, is one of the world's largest consumer healthcare companies (Sensodyne toothpaste, Panadol painkiller). Its daily price change reflects the sector's inherent volatility. This metric is important for formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma other
Haleon plc is a global leader in the over-the-counter consumer health care market. This chart shows the average daily volatility of the sector. Comparing it to HLN's performance helps us understand how its portfolio of well-known brands (Sensodyne, Panadol) makes its business defensive.
Daily change in the price of a broad market stock, index - GURU.Markets
Haleon, a spinoff from GSK, is a global leader in consumer health products (Sensodyne toothpaste, Advil pain reliever). This sector is considered defensive. The chart below shows the overall market volatility, which often makes Haleon's performance appear calmer.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Haleon plc
Haleon, spun off from GSK, is now a giant in the over-the-counter consumer health care industry, owning brands such as Sensodyne and Advil. Its year-over-year growth reflects stable demand for its products, which is largely unaffected by economic cycles.
Annual dynamics of market capitalization of the market segment - Pharma other
Haleon plc, spun off from GSK, is one of the world's largest companies specializing in over-the-counter consumer healthcare products (Advil, Sensodyne). Its strength lies in its well-known brands and global reach. The chart below shows how this stable and predictable business compares to the pharmaceutical sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Haleon is a global leader in over-the-counter consumer health products (such as Sensodyne toothpaste and Advil pain reliever), spun off from GSK. Its business is resilient to economic cycles, as demand for its products is consistent. Haleon shares attract investors seeking stability and dividends.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Haleon plc
For Haleon plc (HLN), a consumer healthcare company, Perf_Month_Co reflects seasonal and promotional sales cycles for over-the-counter medications and personal care products. Medium-term fluctuations in the chart reflect how the market perceives the success of its marketing campaigns, cost inflation management, and the development of its key brand portfolio.
Monthly dynamics of market capitalization of the market segment - Pharma other
This chart reflects the dynamics of the consumer healthcare sector. For Haleon, spun off from GSK, it provides context. It shows how its portfolio of well-known over-the-counter brands (Sensodyne, Panadol) is delivering stable, albeit slow, growth.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Haleon plc, spun off from GSK, is one of the world's largest companies specializing in over-the-counter consumer health products (Advil, Sensodyne). Demand for its products is stable and unaffected by the economy. A broad market chart allows one to assess how the defensive nature of its business has made Haleon shares resilient to general economic downturns.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Haleon plc
The weekly performance of Haleon, a consumer health products company spun off from GSK (Advil, Sensodyne), reflects people's everyday needs. Its stock price responds to consumer spending, demographic trends, and the brand's ability to maintain its strength on pharmacy shelves.
Weekly dynamics of market capitalization of the market segment - Pharma other
The over-the-counter consumer health care sector is a story of strong brands. Weekly trends across the industry reflect consumer spending patterns and demographic trends. The chart illustrates this stable backdrop, against which Haleon competes for a place in home medicine cabinets.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Haleon is a consumer health giant (Sensodyne, Panadol), spun off from GSK. Demand for its products is considered stable. The chart below will help you assess whether Haleon shares exhibit defensive properties: do they demonstrate resilience during general market turbulence or do they move with the market?
Market capitalization of the company, segment and market as a whole
HLN - Market capitalization of the company Haleon plc
Haleon's market capitalization tells the story of the creation of a global consumer health leader following its spinoff from GSK. The chart reflects the strength of brands like Sensodyne and Panadol. Its dynamics are the market's attempt to assess the potential of a focused company operating in the stable and predictable OTC and healthcare market.
HLN - Share of the company's market capitalization Haleon plc within the market segment - Pharma other
Haleon is a global consumer healthcare leader spun out of GSK. The company owns a portfolio of well-known brands such as Sensodyne, Panadol, and Advil. Its huge market share reflects consumer trust. The chart shows the weight of this giant, which focuses exclusively on over-the-counter medications and health products.
Market capitalization of the market segment - Pharma other
Haleon is a global leader in the over-the-counter consumer health products market (Sensodyne, Panadol, Advil), spun off from GSK. The chart below shows the market capitalization of this stable sector. Its dynamics reflect the consistent demand for recognizable brands trusted by consumers worldwide.
Market capitalization of all companies included in a broad market index - GURU.Markets
Haleon is a consumer healthcare giant spun off from GSK, owning brands such as Sensodyne and Advil. Its market capitalization is the value of the trust millions of consumers place in trusted over-the-counter medications. Its stable weight on the overall chart demonstrates the strength of its brands in everyday health care.
Book value capitalization of the company, segment and market as a whole
HLN - Book value capitalization of the company Haleon plc
Haleon, spun off from GSK, is comprised of its OTC and healthcare manufacturing plants, as well as a portfolio of world-renowned brands (Sensodyne, Panadol). This is the tangible capital behind everyday health care. How has this foundation evolved? The chart below shows its steady growth.
HLN - Share of the company's book capitalization Haleon plc within the market segment - Pharma other
Haleon, a spinoff from GSK, produces popular over-the-counter medications at a global network of factories. The chart shows the share of this production capacity in the consumer healthcare sector, reflecting the physical scale required to supply pharmacies worldwide.
Market segment balance sheet capitalization - Pharma other
Global OTC drug production, like Haleon's, is capital-intensive. Compared to its pharmaceutical industry assets, its network of factories producing well-known brands represents a significant physical base necessary for maintaining its leadership.
Book value of all companies included in the broad market index - GURU.Markets
Haleon's assets are a global network of factories inherited from GSK and Pfizer, producing world-renowned over-the-counter brands such as Panadol, Sensodyne, and Voltaren. Its book value reflects the physical scale of production of the healthcare products found in every medicine cabinet. The chart shows the weight of this consumer healthcare giant.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Haleon plc
Haleon, a giant in the over-the-counter (OTC) drug space (Sensodyne, Panadol) spun off from GSK, is valued at a premium to its manufacturing plants. Investors are paying for its portfolio of world-renowned and trusted brands that generate stable cash flow.
Market to book capitalization ratio in a market segment - Pharma other
Haleon is a global leader in over-the-counter consumer health products (Advil, Sensodyne), spun off from GSK. Its strength lies in its strong brands. This chart shows how highly the market values these recognizable names and consumer loyalty, which isn't reflected in the company's balance sheet.
Market to book capitalization ratio for the market as a whole
Haleon is a global leader in over-the-counter consumer healthcare products (Advil, Sensodyne), spun off from GSK. The company's value lies in its portfolio of strong, recognizable brands. This metric demonstrates how the market values a stable and predictable business built on brands that customers have trusted for decades.
Debts of the company, segment and market as a whole
HLN - Company debts Haleon plc
Haleon, a global leader in consumer healthcare (brands Sensodyne and Panadol), was spun off from GSK with a significant debt load. Management's key objective is to gradually reduce debt through stable cash flows from strong brands. This chart illustrates the company's financial strategy following its formation.
Market segment debts - Pharma other
Haleon is a global leader in consumer healthcare, spun off from GSK. The company owns brands such as Sensodyne, Panadol, and Advil. This business generates stable cash flow. The chart shows Haleon's debt level at the start of its independent history and its strategy for managing it to invest in marketing and innovation.
Market debt in general
Haleon is a global consumer healthcare company (e.g., Sensodyne, Panadol), spun off from GSK. Such companies typically have stable cash flows. This chart allows us to assess how Haleon is managing the debt it inherited during the spinoff and how conservative its financial policies are compared to the market.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Haleon plc
Haleon, a spinoff from GSK, is a global leader in consumer healthcare. This chart shows its debt load after the split. Investors closely monitor it to assess how well the company manages its debt and generates sufficient cash flow to service it and invest in its brands.
Market segment debt to market segment book capitalization - Pharma other
Haleon, a global consumer healthcare leader spun off from GSK, owns brands such as Sensodyne and Advil. This chart compares the company's debt to the overall market capitalization of the pharmaceutical sector. It helps understand how the company is managing its financial profile post-splitting and using capital to advance its established brands.
Debt to book value of all companies in the market
Haleon, a consumer healthcare giant, operates in the defensive sector. This chart plots the company's debt against the overall market capitalization. It clearly demonstrates how stable the FMCG company's financial position is compared to the broader market's volatility.
P/E of the company, segment and market as a whole
P/E - Haleon plc
Haleon is a global leader in consumer healthcare, spun off from GSK. It owns brands such as Sensodyne, Panadol, and Advil. This chart shows how investors value this stable and predictable business. The valuation reflects the strength of its brands and the continued demand for over-the-counter medicines and personal care products.
P/E of the market segment - Pharma other
Haleon is a global consumer healthcare company spun off from GSK. Its portfolio includes well-known brands such as Sensodyne, Panadol, and Advil. This chart shows the average valuation for the pharmaceutical sector, helping to understand how the market values this OTC portfolio.
P/E of the market as a whole
Haleon, spun off from GSK, is a global leader in over-the-counter consumer health products like Sensodyne and Advil. This business is considered stable. Does comparing its valuation to this chart of overall market sentiment confirm its defensive status? Or does inflation and private-label competition make it vulnerable?
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Haleon plc
Haleon is a global leader in over-the-counter consumer healthcare products (e.g., Sensodyne, Panadol), spun off from GSK. It's a stable business focused on strong brands. This chart shows how the market views its ability to generate predictable profits and organic growth.
%20P%2FE%20Haleon%20plc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Haleon-plc&v=1772672239143 "Chart of the company's future (projected) P/E Haleon plc")
Future (projected) P/E of the market segment - Pharma other
Haleon is a global consumer healthcare leader spun off from GSK, owning well-known brands such as Sensodyne, Panadol, and Advil. The data here reflects the company's future profitability forecasts, demonstrating how highly the market values its OTC and healthcare portfolio and its ability to generate consistent revenue.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772672239167 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Haleon, spun off from GSK, is a global leader in over-the-counter healthcare products such as Sensodyne and Advil. Their business is characterized by stable demand. This graph of overall market expectations highlights the appeal of Haleon's predictable revenues in a world of economic uncertainty.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772672239187 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Haleon plc
Haleon is a global consumer healthcare leader spun off from GSK, with a portfolio of brands including Sensodyne and Advil. This chart shows how well the company is performing as an independent entity. Profitability depends on the strength of its brands, innovation, and ability to maintain a leading position on pharmacy shelves.
Profit of companies in the market segment - Pharma other
Haleon is a global consumer healthcare company spun off from GSK. Its portfolio includes brands such as Sensodyne and Advil. This chart shows profitability in the over-the-counter pharmaceuticals sector. The strength of its established brands and stable demand for its products ensure Haleon's stable market position.
Overall market profit
Haleon is one of the world's largest manufacturers of over-the-counter consumer health products (Sensodyne toothpaste, Panadol painkillers). Demand for its products is generally stable, as they are essential items. However, the economic situation, reflected in the graph, may influence consumers' choices between branded products and cheaper alternatives.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Haleon plc
Haleon plc is one of the world's largest consumer healthcare companies, spun off from GSK. It owns the Sensodyne, Panadol, and Advil brands. This chart shows analysts' expectations for future profits, based on stable demand for over-the-counter medications and health care products.
%20profit%20of%20the%20company%20Haleon%20plc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Haleon-plc&v=1772672239279 "Graph of future (projected) profit of the company Haleon plc")
Future (predicted) profit of companies in the market segment - Pharma other
Haleon is a global consumer healthcare leader spun off from GSK, with a portfolio of brands including Sensodyne, Panadol, and Voltaren. The sector's profit projections, shown here, reflect robust demand for over-the-counter medications. This chart helps understand how Haleon is leveraging the strength of its established brands to grow in this competitive market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772672239294 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
Haleon is a global consumer healthcare company spun off from GSK. It produces over-the-counter medications and oral hygiene products (e.g., Sensodyne, Panadol). Demand for its products is relatively stable, but rising disposable incomes, associated with the positive outlook in this chart, could boost sales.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772672239303 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Haleon plc
Haleon is a global consumer healthcare leader spun off from GSK, with brands like Sensodyne and Advil. This chart shows how the market values its OTC drug revenue. A stable valuation reflects the strength of established brands and resilient demand for healthcare products, which is less susceptible to economic downturns.
P/S market segment - Pharma other
Haleon is a global consumer healthcare leader spun out of GSK. The company owns well-known brands such as Sensodyne, Panadol, and Voltaren. It is a stable business with predictable revenue. This chart shows the average valuation in the sector, helping to understand how the market views Haleon's portfolio of strong brands and its independent future.
P/S of the market as a whole
Haleon is a global leader in consumer healthcare, spun off from GSK. The company owns well-known brands such as Sensodyne, Panadol, Voltaren, and Centrum. This chart compares how the market values stable revenue from OTC and healthcare products against overall market valuations.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Haleon plc
Haleon is one of the world's largest over-the-counter consumer health care companies (e.g., Sensodyne, Panadol), spun off from GSK. This chart shows how investors estimate its future stable earnings. This valuation is based on the strength of its brands and the robust demand for its health products.
%20P%2FS%20Haleon%20plc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Haleon-plc&v=1772672239414 "The graph of the company's future (projected) P/S Haleon plc")
Future (projected) P/S of the market segment - Pharma other
Haleon is a global consumer healthcare company spun off from GSK, owning brands such as Sensodyne, Panadol, and Voltaren. This chart compares the company's estimated future sales with other pharmaceutical companies, showing how investors view its ability to grow as an independent company, leveraging the strength of its established brands.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772672239429 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
Haleon is a global leader in consumer healthcare, owning brands such as Sensodyne, Panadol, and Advil. Demand for its products is stable and unaffected by economic cycles, as health is a fundamental need. Amid the fluctuating expectations shown by this chart, Haleon demonstrates the resilience typical of protective sectors.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772672239437 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Haleon plc
This figure reflects the revenue of Haleon, a spinoff from GSK and a global leader in over-the-counter consumer health products. Revenue is generated from brands such as Sensodyne, Panadol, and Voltaren. Revenue growth demonstrates stable demand for health and personal care products, as well as the strength of the company's portfolio of well-known and trusted brands.
Sales of companies in the market segment - Pharma other
Haleon is a global leader in the consumer healthcare market, spun off from GSK. The company's portfolio includes well-known brands such as Sensodyne, Panadol, and Voltaren. This chart shows revenue in the consumer pharmaceuticals sector. It reflects the stable demand for over-the-counter medications and personal care products that people purchase regularly, regardless of the economic climate.
Overall market sales
Haleon plc, spun off from GSK, is one of the world's largest producers of over-the-counter consumer health products, including Sensodyne toothpaste and Advil pain reliever. Demand for its products is stable, but rising affluence, reflected in this chart, is enabling consumers to become more health-conscious and purchase branded products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Haleon plc
Haleon is one of the world's largest companies specializing in over-the-counter consumer health products, owning the Sensodyne, Panadol, and Advil brands. This revenue forecast chart reflects consumer health spending. This growth is driven by expectations of robust demand for its well-known and trusted brands worldwide.
%20sales%20of%20the%20company%20Haleon%20plc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Haleon-plc&v=1772672239498 "Schedule of future (projected) sales of the company Haleon plc")
Future (projected) sales of companies in the market segment - Pharma other
Haleon is a major consumer healthcare company spun off from GSK. It owns well-known brands such as Panadol painkiller, Sensodyne toothpaste, and Centrum vitamins. This chart shows projected revenues for the entire over-the-counter pharmaceuticals sector, reflecting consumer demand for health and personal care products.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772672239536 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Haleon is one of the world's largest consumer healthcare companies. Its products, from toothpaste to painkillers, are essential for everyday use. The forecasts for consumer spending growth reflected here support stable demand and allow the company to invest in the development of its brands.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772672239628 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Haleon plc
Haleon is a major consumer healthcare company spun off from GSK. Its portfolio includes brands such as Sensodyne, Panadol, and Advil. This chart demonstrates the stability and profitability of a business built on strong, recognizable brands. Customer loyalty allows the company to maintain high prices and effectiveness.
Market segment marginality - Pharma other
Haleon is a global over-the-counter consumer healthcare company spun off from GSK. Its portfolio includes brands such as Sensodyne, Panadol, and Voltaren. Profitability depends on the strength of its brands and distribution. This chart shows the average profitability in the sector, allowing one to assess the competitiveness and effectiveness of Haleon's portfolio.
Market marginality as a whole
Haleon is one of the world's largest companies specializing in consumer health products (OTC medications, vitamins, and oral care). Demand for its products is stable and weakly dependent on general economic cycles, as reflected in this chart. Health and well-being are basic needs, providing the company with a stable cash flow.
Employees in the company, segment and market as a whole
Number of employees in the company Haleon plc
Haleon is a consumer health giant spun off from GSK. Behind brands like Sensodyne, Panadol, and Advil lies a vast global enterprise. This chart illustrates the scale of its team, which researches, produces, and markets over-the-counter medications and personal care products available in pharmacies worldwide.
Share of the company's employees Haleon plc within the market segment - Pharma other
Haleon is a global consumer healthcare company spun off from GSK (Advil, Sensodyne). The production and marketing of these well-known brands requires a large global workforce. This chart demonstrates its scale as a standalone leader in consumer healthcare, measuring its significant share of employment in the sector.
Number of employees in the market segment - Pharma other
Haleon, spun off from GSK, is one of the world's largest companies specializing exclusively in over-the-counter consumer health products (e.g., Sensodyne, Panadol). This chart demonstrates the scale and stability of this market. It illustrates that maintaining and promoting well-known brands requires a global team of marketers and specialists.
Number of employees in the market as a whole
Haleon, a spinoff from GSK, is home to brands such as Advil and Sensodyne. Its extensive R&D, manufacturing, and marketing teams reflect the stable, non-cyclical demand for over-the-counter health products that people need at all times.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Haleon plc (HLN)
Haleon, spun off from GSK, is a giant in the over-the-counter (OTC) and healthcare market. Its value lies in its portfolio of well-known brands (Sensodyne, Panadol). This chart reflects a business built on marketing and distribution. The company's value is largely determined by the strength of its brands, not just the efforts of its large global workforce.
%20of%20the%20company%20Haleon%20plc%20(HLN)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Haleon-plc-HLN&v=1772672239992 "Chart of market capitalization per employee (in thousands of dollars) of the company Haleon plc (HLN)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Haleon, a spinoff from GSK, owns a portfolio of well-known over-the-counter brands (Sensodyne, Panadol, Advil). Like Colgate, it is a "brand-heavy" business. This metric, compared to the sector average, reflects how highly the market values the strength of these consumer brands per employee (marketer, salesperson).
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772672240024 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Haleon is a global leader in consumer healthcare, owning brands such as Sensodyne and Panadol. This metric reflects the strength of its portfolio of well-known and trusted brands. The company's value is built on consumer loyalty and global distribution, driven by the efforts of its international marketing and sales team.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772672240044 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Haleon plc (HLN)
Haleon is a consumer health giant spun out of GSK. They own the Sensodyne, Advil, and Voltaren brands, which include over-the-counter medications and personal care products. This business is built on brands and distribution. This chart shows how effectively the company manages its portfolio. High profit per employee is a result of the high margins of its well-known brands.
%20Chart%20Haleon%20plc%20(HLN)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Haleon-plc-HLN&v=1772672240062 "Company Profit Per Employee (in thousands of dollars) Chart Haleon plc (HLN)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Haleon is a consumer healthcare giant (Advil, Sensodyne), spun off from GSK. This chart shows the benchmark for Pharma (Consumer Goods). The average profit per employee here is a classic CPG model. The benchmark reflects a balance: profit is generated by brand strength and marketing, not just R&D.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772672240087 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Haleon is a global leader in over-the-counter healthcare products, spun off from GSK. The company's portfolio includes brands such as Sensodyne, Panadol, and Voltaren. This chart shows how effective a business model based on strong brands and mass consumption is in terms of profitability per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772672240096 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Haleon plc (HLN)
Haleon is a global consumer healthcare leader spun off from GSK, with brands such as Sensodyne and Panadol. This chart demonstrates the strength of its portfolio of established brands. High revenue per employee reflects a price premium and consumer loyalty, as well as the efficiency of global distribution.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Haleon-plc-HLN&v=1772672240130 "Sales chart per company employee Haleon plc (HLN)")
Sales per employee in the market segment - Pharma other
Haleon is a global leader in consumer healthcare (brands Sensodyne, Panadol, and Advil), spun off from GSK. Their business encompasses marketing, R&D, and over-the-counter sales. This chart shows the average per-employee income for the sector. It helps assess how effectively Haleon monetizes the strength of its brands through its team.
Sales per employee for the market as a whole
Haleon is a consumer health giant spun off from GSK. They own brands such as Sensodyne, Advil, Voltaren, and Centrum. Their business focuses on over-the-counter medications and personal care. This chart shows how effectively their team, managing these well-known brands, generates revenue through global distribution.
Short shares by company, segment and market as a whole
Shares shorted by company Haleon plc (HLN)
Haleon, a spinoff from GSK, owns a portfolio of well-known over-the-counter brands (Sensodyne, Advil, Panadol). This chart shows bearish sentiment. Skeptics may fear that consumers will switch to cheaper private label alternatives amid inflation or that the company's growth will be too slow.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Haleon-plc-HLN&v=1772672240210 "Short Shares Chart for the Company Haleon plc (HLN)")
Shares shorted by market segment - Pharma other
Haleon is a consumer health giant spun off from GSK. They own the Sensodyne, Voltaren, Panadol, and Advil brands, including over-the-counter medications and personal care products. This chart shows bearish bets. The Haleon shorts may be linked to concerns that, in the face of inflation, consumers will switch to cheaper generics and pharmacy-owned brands rather than Haleon's branded products.
Shares shorted by the overall market
Haleon is one of the world's largest manufacturers of over-the-counter consumer health products (Advil, Sensodyne, Centrum). This business is synonymous with stability. This market pessimism indicator may rise, but consumers won't stop buying painkillers or toothpaste. Haleon's brands are essential, making the company a classic defensive asset.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Haleon plc (HLN)
Haleon, spun off from GSK, is a giant in over-the-counter (OTC) drugs and health products (Advil, Sensodyne). It's a defensive sector. An oscillator above 70 may reflect earnings stability or a flight to "safe" stocks. A level below 30 may reflect concerns about rising costs or competition.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Haleon-plc-HLN&v=1772672240616 "RSI 14 indicator chart for the company's stock Haleon plc (HLN)")
RSI 14 Market Segment - Pharma other
Haleon (HLN) is a consumer business spun off from GSK. They own brands like Sensodyne, Panadol, and Voltaren. It's a defensive but slow-growing business. This indicator shows the "temperature" of the sector. It helps us understand: is HLN oversold due to its debt, or is the entire consumer sector "cooled?"
RSI 14 for the overall market
Haleon is a consumer health giant spun off from GSK. The company owns brands such as Sensodyne and Advil. It's a stable yet competitive business. This chart shows overall investor sentiment. It helps us understand whether HLN's fluctuations are driven by general market panic or euphoria, rather than by the strength of its brands and pharmacy sales.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast HLN (Haleon plc)
Haleon is a global leader in consumer healthcare, spun off from GSK. It owns brands such as Sensodyne, Advil, and Voltaren. This chart aggregates Wall Street forecasts. It shows the average price target analysts expect in a year, assessing the strength of the company's brands and their ability to increase prices.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-HLN-Haleon-plc&v=1772672240675 "A chart showing analyst consensus forecasts for the expected stock price. HLN (Haleon plc)")
The difference between the consensus estimate and the actual stock price HLN (Haleon plc)
Haleon (HLN) is a consumer health giant spun off from GSK. Their portfolio includes brands such as Sensodyne toothpaste, Advil painkillers, and Centrum vitamins. This chart shows the valuation of the over-the-counter brands. It shows the gap between the price and the consensus target, reflecting the potential analysts see in their stable business.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-HLN-Haleon-plc&v=1772672240729 "A chart showing the difference between the consensus forecast and the actual stock price. HLN (Haleon plc)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Haleon is a global consumer healthcare leader (formerly a division of GSK), owning the Sensodyne, Advil, and Voltaren brands. It's a "defensive" business built on brand strength. This chart shows analysts' overall expectations for the sector. It reflects whether experts believe consumers will continue to buy branded medications.
Analysts' consensus forecast for the overall market share price
Haleon plc is a global leader in over-the-counter consumer healthcare products, spun off from GSK. Its portfolio includes brands such as Sensodyne, Panadol, and Advil. It is a defense business. This chart reflects the overall market sentiment. For Haleon, it serves as a backdrop: during periods of market pessimism, their stable demand for essential products is particularly attractive to investors.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Haleon plc
Haleon is a global consumer healthcare giant spun off from GSK. Their portfolio includes brands found in nearly every medicine cabinet (Sensodyne, Panadol, Advil). This chart is a stability indicator. It reflects the strength of their brands, the company's ability to raise prices (to combat inflation), and their performance as an independent company focused on over-the-counter products.
AKIMA Market Segment Index - Pharma other
Haleon is a consumer health giant (spinned off from GSK), owning a portfolio of billion-dollar brands such as Sensodyne toothpaste, Advil painkillers, and Panadol. This composite metric evaluates companies. The chart shows the sector average. This benchmark: how does Haleon's stable and branded business differentiate it from the average competitor?
The AKIM Index for the overall market
Haleon is a consumer business (Sensodyne toothpaste, Advil painkiller) spun out of pharmaceutical giants GSK and Pfizer. It's a classic defensive sector. This chart, showing the market average, is the backdrop. It helps assess how this stable, predictable business fares against the backdrop of overall macroeconomic fluctuations, which this indicator reflects.
